ETO-2 Polyclonal Antibody

{pboot:if('CBFA2T3;MTG16;MTGR2;ZMYND4;Protein CBFA2T3;MTG8-related protein 2;Myeloid translocation gene on chromosome 16 protein;hMTG16;Zinc finger MYND domain-containing protein 4'!='')}Alias:CBFA2T3;MTG16;MTGR2;ZMYND4;Protein CBFA2T3;MTG8-related protein 2;Myeloid translocation gene on chromosome 16 protein;hMTG16;Zinc finger MYND domain-containing protein 4{/pboot:if}

CatalogNo:HJRLT1643

Specifications

50μL;100μL

Delivery date

Spot

Target

ETO-2

Reactivity

Human,Mouse

Application - After Update

IHC,IF,ELISA

MW(Calculated)

71kD

Host Species

Rabbit

Isotype

IgG

Modify

Unmodified

Recommended dilution ratio

IHC 1:100-1:300;ELISA 1:20000;IF 1:50-200

compose

Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.

Store

-15°C to -25°C/1 year(Do not lower than -25°C)

Soncentration

1 mg/ml

Clonality

Polyclonal

Immunogen

The antiserum was produced against synthesized peptide derived from human MTG16. AA range:261-310

Specificity

ETO-2 Polyclonal Antibody detects endogenous levels of ETO-2 protein.

Gene name

CBFA2T3

Protein name

Protein CBFA2T3

Organism-1

Human